Table 4

Estimated associations between selected factors and referral completion in Nigeria

Nigeria
N*Referral completion (%)Adjusted OR**95% CIP value
All60047.8
Study group by enrolment location
CHW
Pre-RAS1486.1Ref.
Post-RAS
No RAS use7621.13.971.07 to 14.750.04
RAS use9126.49.952.71 to 36.58<0.001
PHC†
Pre-RAS5879.3Ref.
Post-RAS
No RAS use10795.335.096.52 to 188.75<0.001
RAS use12075.06.451.62 to 25.670.01
Enrolment location
CHW31515.6Ref.
PHC†28583.519.792.97 to 131.710.002
CNS involvement‡
No9933.3Ref.
Yes50150.70.480.17 to 1.380.17
Enrolled during rainy season§
No15450.6Ref.
Yes44646.90.700.29 to 1.670.42
Enrolled on a workday
No10730.8Ref.
Yes49351.50.740.31 to 1.760.50
Enrolled during COVID-19 pandemic
No48349.5Ref.
Yes11741.00.090.03 to 0.26<0.001
Delay to enrolling provider
0–1 days19745.7Ref.
>1 day32747.11.640.77 to 3.520.20
Missing7656.63.531.03 to 12.090.04
Transport to enrolling provider
No vehicle/missing¶37133.7Ref.
Vehicle22970.70.820.32 to 2.100.68
Time to referral health facility (min)
0–<1510481.7Ref.
15–<308771.30.480.13 to 1.730.26
30–<6014955.70.230.07 to 0.770.02
≥6024719.40.060.02 to 0.22<0.001
Missing1369.20.130.01 to 1.840.13
Perceived severity
Not fatal43448.8Ref.
Fatal16144.70.630.30 to 1.320.23
Missing560.01.230.01 to 153.000.93
Home treatment
No/missing¶37943.8Ref.
Yes22154.81.080.54 to 2.160.82
  • *OR additionally adjusted for child sex, child age, caregiver sex, caregiver age, location of residence (LGA) and malaria test result.

  • †Adjusted for LGA. OR shown for Mayo-Belwa. ORs for Fufore and Song are higher.

  • ‡Danger signs involving the CNS: convulsions, unusually sleepy or unconscious.

  • §May–October.

  • ¶Observations with missing values added to reference category because no meaningful OR could be computed due to the data structure (missing values in other covariates).

  • **Denominator.

  • CHW, community health worker; CNS, central nervous system; PHC, primary health centre; RAS, rectal artesunate.